Across rheumatic diseases

Body Mass Index and the Risk of Rheumatic Disease: Linear and Nonlinear Mendelian Randomization Analyses

Arthritis RheumatolPublished Mendelian randomisation study

Authors' conclusion

Higher BMI causes an increased risk for rheumatic disease, an effect that is more pronounced in women for both gout and psoriatic arthropathy.

Study context

Population
UK Biobank cohort participants; 5 rheumatic diseases: RA (n = 8,381 cases), OA, psoriatic arthropathy, gout, inflammatory spondylitisUK Biobank · OA 87,430 · psoriatic arthropathy 933 · gout 13,638 · inflammatory spondylitis 4,328
Participants
361,952 participants
Comparison
Genetically predicted body mass index (BMI)
Outcome
Incidence of RA, OA, psoriatic arthropathy, gout and inflammatory spondylitis
Methodological detailslinear and nonlinear mendelian randomization, sex-specific analyses
  • Linear and nonlinear mendelian randomization
  • Sex-specific analyses

Main finding

As reported in the abstract

Incidence per 1 SD increase in BMI (linear MR, all individuals)
RA, IRR
1.52 (1.36-1.69) (95% CI)
OA, IRR
1.49 (1.43-1.55) (95% CI)
Psoriatic arthropathy, IRR
1.80 (1.31-2.48) (95% CI)
Gout, IRR
1.73 (1.56-1.92) (95% CI)
Inflammatory spondylitis, IRR
1.34 (1.14-1.57) (95% CI)

Further findings

Sex interaction: BMI a stronger risk factor in women vs men

Psoriatic arthropathy, P for sex interaction
3.3 × 10-4
Gout, P for sex interaction
4.3 × 10-3

OA: effect stronger in premenopausal vs postmenopausal women

P
1.8 × 10-3

Nonlinear effects of BMI

Nonlinearity for gout more extreme in men vs women, P
0.03
Nonlinear effects identified for OA and gout in men, and for gout in women
  • Nonlinear mendelian randomization (MR)

Original publication

Body Mass Index and the Risk of Rheumatic Disease: Linear and Nonlinear Mendelian Randomization Analyses. Arthritis Rheumatol. Published 28 September 2023. doi:10.1002/art.42613

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.